Bank of America’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Bank of America’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-4,300	Closed	-$140K	–	7455
2018 Q1	$140K	Buy	+4,300	New	+$189K	﹤0.01%	5557
2017 Q3	–	Sell	-9,500	Closed	-$534K	–	7390
2017 Q2	$534K	Buy	+9,500	New	+$380K	﹤0.01%	4856
2016 Q2	–	Sell	-240,300	Closed	-$4.9M	–	7525
2016 Q1	$4.9M	Buy	+240,300	New	+$7.62M	﹤0.01%	2795

Bank of America's PTLA Position: Q3 2020 in Review

Bank of America sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 554,943 shares — an estimated $9.98M sold.

Bank of America first reported a position in PTLA in Q2 2013 and held it in 29 quarters. The position peaked at $20.8M in Q1 2019. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

Bank of America reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Bank of America sold 554,943 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $9.98M.
Bank of America first reported a position in Portola Pharmaceuticals, Inc. in Q2 2013 and held it in 29 quarters.
Bank of America's Portola Pharmaceuticals, Inc. position peaked at $20.8M in Q1 2019.
0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Bank of America's 13F filing for Q3 2020, filed 13 Nov 2020.